On the monitoring of dabigatran treatment in “real life” patients with atrial fibrillation

M Skeppholm, P Hjemdahl, JP Antovic, J Muhrbeck… - Thrombosis research, 2014 - Elsevier
Introduction The oral direct thrombin inhibitor dabigatran is increasingly used to prevent
thromboembolic stroke in patients with atrial fibrillation (AF). Routine laboratory monitoring is …
被引用次数：71 相关文章

On the monitoring of dabigatran treatment in “real life” patients with atrial fibrillation

M Skeppholm, P Hjemdahl, JP Antovic, J Muhrbeck… - Thrombosis …, 2014 - infona.pl
The oral direct thrombin inhibitor dabigatran is increasingly used to prevent thromboembolic
stroke in patients with atrial fibrillation (AF). Routine laboratory monitoring is currently not …

On the monitoring of dabigatran treatment in" real life" patients with atrial fibrillation.

M Skeppholm, P Hjemdahl, JP Antovic… - Thrombosis …, 2014 - europepmc.org
Results Total plasma dabigatran varied 20-fold (12-237 ng/mL with 150 mg BID) and
correlated well with free dabigatran (r (2)= 0.93). There were strong correlations between LC …

On the monitoring of dabigatran treatment in “real life” patients with atrial fibrillation

M Skeppholm, P Hjemdahl, JP Antovic… - Thrombosis …, 2014 - thrombosisresearch.com
Introduction The oral direct thrombin inhibitor dabigatran is increasingly used to prevent
thromboembolic stroke in patients with atrial fibrillation (AF). Routine laboratory monitoring is …

On the monitoring of dabigatran treatment in" real life" patients with atrial fibrillation

M Skeppholm, P Hjemdahl, JP Antovic… - Thrombosis …, 2014 - pubmed.ncbi.nlm.nih.gov
Introduction The oral direct thrombin inhibitor dabigatran is increasingly used to prevent
thromboembolic stroke in patients with atrial fibrillation (AF). Routine laboratory monitoring is …